HF
KPRX icon

HRT Financial’s Kiora Pharmaceuticals KPRX Stock Holding History

HRT Financial’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
+58,612
New +$147K ﹤0.01% 3483
2024
Q2 		– Sell
-2,540
Closed -$16K – 2676
2024
Q1 		$16K Buy
+2,540
New +$14.2K ﹤0.01% 2027
2023
Q3 		– Sell
-1,497
Closed -$8K – 2769
2023
Q2 		$8K Buy
+1,497
New +$31.4K ﹤0.01% 2188
2021
Q4 		– Sell
-28
Closed -$22K – 3651
2021
Q3 		$22K Buy
+28
New +$23.8K ﹤0.01% 3140

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial's KPRX Position: Q2 2026 in Review

HRT Financial opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 58,612 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #3483 among its holdings. This is a return to the name: HRT Financial previously reported a position in KPRX as recently as Q1 2024.

HRT Financial first reported a position in KPRX in Q3 2021 and has held it in 4 quarters since. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • HRT Financial held 58,612 shares of Kiora Pharmaceuticals worth $154K as of Q2 2026.
  • Kiora Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3483 holding.
  • HRT Financial first reported a position in Kiora Pharmaceuticals in Q3 2021 and has held it in 4 quarters since.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.